Curogen, one of South Korea's leading biotechnology companies focused on nanotechnology-based treatments for autoimmune diseases, today announced a series of strategic appointments that strengthen its ...

INB-200 is well-tolerated, showing no serious toxicities beyond those typically observed with chemotherapy. Importantly no ...

Avoid travel to these 5 COVID-19 hotspots in 2025 amid rising cases from the NB.1.8.1 variant. Stay updated and prioritize ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Stratus Therapeutics, Inc. ("Stratus”), a biotechnology company developing on-demand hematopoietic stem cell (HSC) therapies, ...

The scientists opine that the results from the exercise programme could change the way colon cancer is treated across the ...

The findings indicate cancer patients should increase their physical activity after treatment, experts said. View on euronews ...